ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antisense Oligonucleotide Therapies Market Research Report 2025
Published Date: 2025-07-07
|
Report Code: QYRE-Auto-17N13175
Home | Market Reports
Global Antisense Oligonucleotide Therapies Market Research Report 2023
BUY CHAPTERS

Global Antisense Oligonucleotide Therapies Market Research Report 2025

Code: QYRE-Auto-17N13175
Report
2025-07-07
Pages:61
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku

Antisense Oligonucleotide Therapies Market

The global market for Antisense Oligonucleotide Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antisense Oligonucleotide Therapies in Genetic Disease is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antisense Oligonucleotide Therapies include Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide Therapies.
The Antisense Oligonucleotide Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antisense Oligonucleotide Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotide Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antisense Oligonucleotide Therapies Market Report

Report Metric Details
Report Name Antisense Oligonucleotide Therapies Market
Segment by Type
  • Without GalNAc-conjugated
  • With GalNAc-conjugated
Segment by Application
  • Genetic Disease
  • Cancer
  • Cardiovascular Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antisense Oligonucleotide Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Oligonucleotide Therapies Market report?

Ans: The main players in the Antisense Oligonucleotide Therapies Market are Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku

What are the Application segmentation covered in the Antisense Oligonucleotide Therapies Market report?

Ans: The Applications covered in the Antisense Oligonucleotide Therapies Market report are Genetic Disease, Cancer, Cardiovascular Diseases, Other

What are the Type segmentation covered in the Antisense Oligonucleotide Therapies Market report?

Ans: The Types covered in the Antisense Oligonucleotide Therapies Market report are Without GalNAc-conjugated, With GalNAc-conjugated

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotide Therapies Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotide Therapies Market Perspective (2020-2031)
2.2 Global Antisense Oligonucleotide Therapies Growth Trends by Region
2.2.1 Global Antisense Oligonucleotide Therapies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antisense Oligonucleotide Therapies Historic Market Size by Region (2020-2025)
2.2.3 Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2026-2031)
2.3 Antisense Oligonucleotide Therapies Market Dynamics
2.3.1 Antisense Oligonucleotide Therapies Industry Trends
2.3.2 Antisense Oligonucleotide Therapies Market Drivers
2.3.3 Antisense Oligonucleotide Therapies Market Challenges
2.3.4 Antisense Oligonucleotide Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue
3.1.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue (2020-2025)
3.1.2 Global Antisense Oligonucleotide Therapies Revenue Market Share by Players (2020-2025)
3.2 Global Antisense Oligonucleotide Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antisense Oligonucleotide Therapies Revenue
3.4 Global Antisense Oligonucleotide Therapies Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotide Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotide Therapies Revenue in 2024
3.5 Global Key Players of Antisense Oligonucleotide Therapies Head office and Area Served
3.6 Global Key Players of Antisense Oligonucleotide Therapies, Product and Application
3.7 Global Key Players of Antisense Oligonucleotide Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotide Therapies Breakdown Data by Type
4.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Type (2020-2025)
4.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2026-2031)
5 Antisense Oligonucleotide Therapies Breakdown Data by Application
5.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Application (2020-2025)
5.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antisense Oligonucleotide Therapies Market Size (2020-2031)
6.2 North America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antisense Oligonucleotide Therapies Market Size by Country (2020-2025)
6.4 North America Antisense Oligonucleotide Therapies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide Therapies Market Size (2020-2031)
7.2 Europe Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antisense Oligonucleotide Therapies Market Size by Country (2020-2025)
7.4 Europe Antisense Oligonucleotide Therapies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide Therapies Market Size (2020-2031)
8.2 Asia-Pacific Antisense Oligonucleotide Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2020-2025)
8.4 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotide Therapies Market Size (2020-2031)
9.2 Latin America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2020-2025)
9.4 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide Therapies Market Size (2020-2031)
10.2 Middle East & Africa Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2020-2025)
10.4 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Details
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2020-2025)
11.1.5 Ionis Pharmaceuticals Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Antisense Oligonucleotide Therapies Introduction
11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2020-2025)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Details
11.3.2 Nippon Shinyaku Business Overview
11.3.3 Nippon Shinyaku Antisense Oligonucleotide Therapies Introduction
11.3.4 Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2020-2025)
11.3.5 Nippon Shinyaku Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
List of Tables
 Table 1. Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Without GalNAc-conjugated
 Table 3. Key Players of With GalNAc-conjugated
 Table 4. Global Antisense Oligonucleotide Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Antisense Oligonucleotide Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Antisense Oligonucleotide Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Antisense Oligonucleotide Therapies Market Share by Region (2020-2025)
 Table 8. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Antisense Oligonucleotide Therapies Market Share by Region (2026-2031)
 Table 10. Antisense Oligonucleotide Therapies Market Trends
 Table 11. Antisense Oligonucleotide Therapies Market Drivers
 Table 12. Antisense Oligonucleotide Therapies Market Challenges
 Table 13. Antisense Oligonucleotide Therapies Market Restraints
 Table 14. Global Antisense Oligonucleotide Therapies Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Antisense Oligonucleotide Therapies Market Share by Players (2020-2025)
 Table 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2024)
 Table 17. Ranking of Global Top Antisense Oligonucleotide Therapies Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotide Therapies Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Antisense Oligonucleotide Therapies, Headquarters and Area Served
 Table 20. Global Key Players of Antisense Oligonucleotide Therapies, Product and Application
 Table 21. Global Key Players of Antisense Oligonucleotide Therapies, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Antisense Oligonucleotide Therapies Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2020-2025)
 Table 25. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2026-2031)
 Table 27. Global Antisense Oligonucleotide Therapies Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2020-2025)
 Table 29. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2026-2031)
 Table 31. North America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Antisense Oligonucleotide Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Antisense Oligonucleotide Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Antisense Oligonucleotide Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Antisense Oligonucleotide Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Antisense Oligonucleotide Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Ionis Pharmaceuticals Company Details
 Table 47. Ionis Pharmaceuticals Business Overview
 Table 48. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Product
 Table 49. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2020-2025) & (US$ Million)
 Table 50. Ionis Pharmaceuticals Recent Development
 Table 51. Sarepta Therapeutics Company Details
 Table 52. Sarepta Therapeutics Business Overview
 Table 53. Sarepta Therapeutics Antisense Oligonucleotide Therapies Product
 Table 54. Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2020-2025) & (US$ Million)
 Table 55. Sarepta Therapeutics Recent Development
 Table 56. Nippon Shinyaku Company Details
 Table 57. Nippon Shinyaku Business Overview
 Table 58. Nippon Shinyaku Antisense Oligonucleotide Therapies Product
 Table 59. Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2020-2025) & (US$ Million)
 Table 60. Nippon Shinyaku Recent Development
 Table 61. Research Programs/Design for This Report
 Table 62. Key Data Information from Secondary Sources
 Table 63. Key Data Information from Primary Sources
 Table 64. Authors List of This Report


List of Figures
 Figure 1. Antisense Oligonucleotide Therapies Picture
 Figure 2. Global Antisense Oligonucleotide Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antisense Oligonucleotide Therapies Market Share by Type: 2024 VS 2031
 Figure 4. Without GalNAc-conjugated Features
 Figure 5. With GalNAc-conjugated Features
 Figure 6. Global Antisense Oligonucleotide Therapies Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Antisense Oligonucleotide Therapies Market Share by Application: 2024 VS 2031
 Figure 8. Genetic Disease Case Studies
 Figure 9. Cancer Case Studies
 Figure 10. Cardiovascular Diseases Case Studies
 Figure 11. Other Case Studies
 Figure 12. Antisense Oligonucleotide Therapies Report Years Considered
 Figure 13. Global Antisense Oligonucleotide Therapies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Antisense Oligonucleotide Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Antisense Oligonucleotide Therapies Market Share by Region: 2024 VS 2031
 Figure 16. Global Antisense Oligonucleotide Therapies Market Share by Players in 2024
 Figure 17. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide Therapies Revenue in 2024
 Figure 19. North America Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Antisense Oligonucleotide Therapies Market Share by Country (2020-2031)
 Figure 21. United States Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Antisense Oligonucleotide Therapies Market Share by Country (2020-2031)
 Figure 25. Germany Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2020-2031)
 Figure 33. China Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Antisense Oligonucleotide Therapies Market Share by Country (2020-2031)
 Figure 41. Mexico Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Antisense Oligonucleotide Therapies Market Share by Country (2020-2031)
 Figure 45. Turkey Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Antisense Oligonucleotide Therapies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2020-2025)
 Figure 49. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2020-2025)
 Figure 50. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2020-2025)
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions